Implant Sciences Issues $20 Million Secured Promissory Notes

On March 21 MBBP client Implant Sciences Corporation announced it had completed a $20,000,000 refinancing with an accredited New York City-based institutional investor group.  Implant Sciences used the proceeds of the loan to pay down its DMRJ Group LLC line of credit as well as some portions of its other indebtedness to DMRJ. Glenn Bolduc, President and CEO …

Continue reading Implant Sciences Issues $20 Million Secured Promissory Notes

Implant Sciences Receives STAC Certification for QS-B220 Explosives Trace Detector

On October 1, MBBP client Implant Sciences Corporation announced that the Service Technique de l'Aviation Civile (STAC) of France has certified QS-B220 desktop explosives trace detector (ETD). The QS-B220 is now available for purchase and deployment to screen passengers, cargo, cabins, and baggage for explosives in airports throughout France. Implant Sciences CEO, Glenn Bolduc, had this to …

Continue reading Implant Sciences Receives STAC Certification for QS-B220 Explosives Trace Detector

Implant Sciences Wins TSA Approval

On January 16, 2013, MBBP client Implant Sciences Corporation announced that its QS-B220 explosives and narcotics trace detector has been accepted into the “Approved” section of the Transportation Security Administration (TSA)'s Air Cargo Screening Technology List (ACSTL). The “Approved” technology section of the list specifies equipment that has been conditionally approved for screening operations and …

Continue reading Implant Sciences Wins TSA Approval